Surgalign Holdings, Inc. provided revenue guidance for the year 2022. For the year, the Company anticipates full year revenue in the range of $83 million to $87 million.
Surgalign Holdings, Inc.
Equities
SRGA
US86882C2044
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+33.63% | 8.68B | |
+38.91% | 4.56B | |
-29.81% | 2.72B | |
-9.44% | 1.61B | |
-21.59% | 1.34B | |
-37.12% | 1.08B | |
+2.26% | 929M | |
-42.75% | 791M | |
-23.56% | 675M |